Research programme: antibody drug conjugates - Suzhou GeneQuantum Healthcare
Latest Information Update: 23 Nov 2023
At a glance
- Originator Suzhou GeneQuantum Healthcare
- Class Antibodies; Drug conjugates; Immunoconjugates
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Unspecified